Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Barinthus Biotherapeutics (BRNS) Depreciation & Amortization (CF) (2020 - 2026)

Barinthus Biotherapeutics filings provide 7 years of Depreciation & Amortization (CF) readings, the most recent being $856000.0 for Q1 2026.

  • On a quarterly basis, Depreciation & Amortization (CF) fell 57.92% to $856000.0 in Q1 2026 year-over-year; TTM through Mar 2026 was $4.7 million, a 27.12% decrease, with the full-year FY2025 number at $5.8 million, up 0.78% from a year prior.
  • Depreciation & Amortization (CF) hit $856000.0 in Q1 2026 for Barinthus Biotherapeutics, down from $909000.0 in the prior quarter.
  • In the past five years, Depreciation & Amortization (CF) ranged from a high of $2.0 million in Q1 2025 to a low of $856000.0 in Q1 2026.
  • Median Depreciation & Amortization (CF) over the past 5 years was $1.3 million (2023), compared with a mean of $1.3 million.
  • Biggest five-year swings in Depreciation & Amortization (CF): skyrocketed 1297.65% in 2022 and later plummeted 57.92% in 2026.
  • Barinthus Biotherapeutics' Depreciation & Amortization (CF) stood at $1.2 million in 2022, then grew by 21.92% to $1.4 million in 2023, then fell by 0.49% to $1.4 million in 2024, then crashed by 36.34% to $909000.0 in 2025, then fell by 5.83% to $856000.0 in 2026.
  • The last three reported values for Depreciation & Amortization (CF) were $856000.0 (Q1 2026), $909000.0 (Q4 2025), and $901000.0 (Q3 2025) per Business Quant data.